3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Lymphoma
2
Leukemia
2
Skin Neoplasms
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Glioma
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
fludarabine phosphate
16
Peripheral Blood Stem Cell Transplantation
16
Cyclophosphamide
16
Mycophenolic Acid
14
Whole-Body Irradiation
13
Cyclosporine
12
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Etoposide
7
Cyclosporins
7
Melphalan
6
Sirolimus
5
Radiotherapy
5
Cytarabine
5
Filgrastim
4
Cord Blood Stem Cell Transplantation
4
ruxolitinib
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Alemtuzumab
3
thymoglobulin
2
sargramostim
2
Pentostatin
2
Methylprednisolone
2
Flow Cytometry
2
Carmustine
2
Carboplatin
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic-Myeloproliferative Diseases
×
peginterferon alfa-2b
×
Clear all
No trials found.